Nadezda Dolgikh

Frankfurt Am Main, HE 60528, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Menin inhibitor ziftomenib (KO-539) synergizes with drugs targeting chromatin regulation or apoptosis and sensitizes acute myeloid leukemia with MLL rearrangement or NPM1 mutation to venetoclax.

Menin inhibitor ziftomenib (KO-539) synergizes with drugs targeting chromatin regulation or apoptosis and sensitizes acute myeloid leukemia with MLL rearrangement or NPM1 mutation to venetoclax.

Journal: Haematologica

Published: September 25, 2022

Co-targeting MCL-1 and ERK1/2 kinase induces mitochondrial apoptosis in rhabdomyosarcoma cells.

Co-targeting MCL-1 and ERK1/2 kinase induces mitochondrial apoptosis in rhabdomyosarcoma cells.

Journal: Translational oncology

Published: December 03, 2021

Selective BH3 mimetics synergize with BET inhibition to induce mitochondrial apoptosis in rhabdomyosarcoma cells.

Selective BH3 mimetics synergize with BET inhibition to induce mitochondrial apoptosis in rhabdomyosarcoma cells.

Journal: Neoplasia (New York, N.Y.)

Published: March 23, 2021

Smac mimetics and TRAIL cooperate to induce MLKL-dependent necroptosis in Burkitt's lymphoma cell lines.

Smac mimetics and TRAIL cooperate to induce MLKL-dependent necroptosis in Burkitt's lymphoma cell lines.

Journal: Neoplasia (New York, N.Y.)

Published: January 18, 2021

The IRE1 and PERK arms of the unfolded protein response promote survival of rhabdomyosarcoma cells.

The IRE1 and PERK arms of the unfolded protein response promote survival of rhabdomyosarcoma cells.

Journal: Cancer letters

Published: April 15, 2020

Targeting ferroptosis in rhabdomyosarcoma cells.

Targeting ferroptosis in rhabdomyosarcoma cells.

Journal: International journal of cancer

Published: January 11, 2019

Co-inhibition of BET proteins and PI3Kα triggers mitochondrial apoptosis in rhabdomyosarcoma cells.

Co-inhibition of BET proteins and PI3Kα triggers mitochondrial apoptosis in rhabdomyosarcoma cells.

Journal: Oncogene

Published: January 10, 2019

Rhabdomyosarcoma cells are susceptible to cell death by LDK378 alone or in combination with sorafenib independently of anaplastic lymphoma kinase status.

Rhabdomyosarcoma cells are susceptible to cell death by LDK378 alone or in combination with sorafenib independently of anaplastic lymphoma kinase status.

Journal: Anti-cancer drugs

Published: October 19, 2017

NRAS-Mutated Rhabdomyosarcoma Cells Are Vulnerable to Mitochondrial Apoptosis Induced by Coinhibition of MEK and PI3Kα.

NRAS-Mutated Rhabdomyosarcoma Cells Are Vulnerable to Mitochondrial Apoptosis Induced by Coinhibition of MEK and PI3Kα.

Journal: Cancer research

Published: June 12, 2017

Showing 1-9 of 9

Last Updated: 09/26/2026